SCHEMBL6086953

SCHEMBL6086953

CCc1c(C(=O)c2cc(C)cc(C)c2)n(Cc2occc2C(=O)OC)c(=O)[nH]c1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.35
MEN1 O00255 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
MAPT P10636 2/20 0.34
THRB P10828 1/20 0.34
GAA P10253 3/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
ALDH1A1 P00352 5/20 0.33
HSD17B10 Q99714 2/20 0.33
GSK3B P49841 1/20 0.32
DRD1 P21728 1/20 0.32
KDM4E B2RXH2 3/20 0.31
POLB P06746 1/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
GLA P06280 1/20 0.31
PKM P14618 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7849860 0.93 DHODH (0.33) KMT2AMEN1TDP1SMN1; SMN2MAPT
SCHEMBL6087200 0.87 KMT2A (0.34) KMT2AMEN1TDP1SMN1; SMN2MAPT
SCHEMBL6086801 0.84 DRD1 (0.35) KMT2AMEN1TDP1SMN1; SMN2MAPT
SCHEMBL7851704 0.80 GSK3B (0.32) SMN1; SMN2MAPTTHRBGSK3BDRD1
SCHEMBL7846777 0.78 SMN1; SMN2 (0.34) KMT2AMEN1SMN1; SMN2MAPTTHRB
SCHEMBL6089500 0.77 TPH1 (0.38) KMT2AMEN1TDP1SMN1; SMN2ALDH1A1
SCHEMBL6087483 0.76 MEN1 (0.43) KMT2AMEN1ALDH1A1KDM4EPKM
SCHEMBL12752168 0.76 KMT2A (0.40) KMT2AMEN1TDP1SMN1; SMN2MAPT
SCHEMBL6086765 0.75 MEN1 (0.38) KMT2AMEN1TDP1SMN1; SMN2MAPT
SCHEMBL6089236 0.75 MTNR1A (0.48) KMT2AMAPTTHRBHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6987114-B1 Antiviral pyrimidinedione derivatives and process for the preparation thereof SAMJIN PHARMACEUTICAL CO., LTD (KR) 2006-01-17 US disclosed